M&A / Deals Roche buys AI-powered diagnostics player PathAI PharmaphorumRoche has been working with US AI specialist PathAI for around five years, and has now upgraded that partnership with an offer to buy it for $1.05bn.Read full story pharminent May 7, 2026 (Last updated: May 7, 2026) Pharmaphorum Roche has been working with US AI specialist PathAI for around five years, and has now upgraded that partnership with an offer to buy it for $1.05bn. Read full story Post navigation Previous: UCB and Cancer Research UK form expanded alliance to advance novel cancer therapiesNext: Bayer plans filings for cardiac amyloidosis imaging agent Related Stories M&A / Deals BioMarin spends up to $490m for Alesta’s bone disease candidate pharminent August 19, 2026 M&A / Deals J&J hands lymphoma bispecific CAR T back to AbelZeta pharminent August 17, 2026 M&A / Deals Novo Nordisk and AWS form AI partnership to speed drug discovery pharminent August 17, 2026
